4-Fluoro-3-methoxyphenylboronic acid, 95.0%, 5g

2-(2,3-Dimethoxybenzoyl)-6-methoxypyridine, 97.0%, 1g

Isoxazol-4-ol, 95.0%, 250mg

6-fluoro-3-methoxy-2-methylquinolin-4-amine, 95.0%, 250mg

Tetrahydrofuran, min. 99.5%, for synthesis, 250 ml, glass packaging

Methyl 6-Hydroxy-2-naphthoate, 97.0%, 10g

(2R)-1-BOC-2-PROPYLPYRROLIDINE-2-METHANAMINE, 95.0%, 500mg

Fmoc-(R)-3-amino-3-(4-nitrophenyl)-propionic acid, 97%, 1g

2-Cyanoethyl 3-oxobutanoate, 95+%, 10g

5-METHYLAZEPAN-4-ONE HCL, 95.0%, 50mg

Volumetric flasks class B transparent, 25 ml, 10/19, 2 Piece(s)

5-Fluoro-2,3-dihydro-1H-inden-1-amine, 95.0%, 100mg

(R)-2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide, 98%, 50mg